Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 2013-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The Purpose of This Study is to Evaluate the Efficacy and Safety of Acarbose in Type 2 Diabetic Patients Using Two Different Formulations of Acarbose 50mg.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: EMS
• Treatments: Acarbose

Criteria

Inclusion Criteria:

• Patients must be able to understand the study procedures agree to participate and give written consent.

• Diagnosed with type 2 diabetes mellitus (t2dm)b

• Female patients of childbearing potential (i.e., ovulating, pre-menopausal, not surgically sterile) which agree to use a medically accepted contraceptive regimen for the duration of the study.

Exclusion Criteria:

• Pregnancy or risk of pregnancy.

• Lactation

• Any pathology or past medical condition that can interfere with this protocol

• Other conditions deemed reasonable by the medical investigator as to the disqualification of the individual from study participation.

• Known hypersensitivity / intolerance to acarbose or any of its excipients